Bryostatin 1 in Treating Patients With Metastatic Kidney Cancer
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
Phase II trial to study the effectiveness of bryostatin 1 in treating patients who have
metastatic kidney cancer. Drugs used in chemotherapy use different ways to stop tumor cells
from dividing so they stop growing or die.